• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

84.3000 SEK 0.4000 0.47%

As of 11:29:59 ET on 07/23/2014.

Snapshot for Swedish Orphan Biovitrum AB (SOBI)

Open: 84.5000 Day's Range: 83.6000 - 85.2500 Volume: 514,637
Previous Close: 84.7000 52wk Range: 45.2000 - 94.7500 1-Yr Rtn: +72.04%

Stock Chart for SOBI

No chart data available.
  • SOBI:SS 84.6500
  • 1D
  • 1M
  • 1Y
84.7000
Interactive SOBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SOBI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 379.7297
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -1.3826
Est. EPS (SEK) (12/2014) 0.2220
Est. PEG Ratio -
Market Cap (M SEK) 22,793.86
Shares Outstanding (M) 270.39
30 Day Average Volume 388,306
Price/Book (mrq) 5.0048
Price/Sale (ttm) 9.5001
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SOBI

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for SOBI

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SOBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil